BioCap wouldn't be possible without our fabulous sponsors: ✅ STFC ✅ Mills & Reeve ✅ RSM UK ✅ Appleyard Lees IP LLP ✅ Boyds Join them plus businesses, researchers and investors for the Investor Mixer Event on 25th and the BioCap conference on 26th September (combined tickets available): https://lnkd.in/ewXVTdWH #BioCap #Investment #Funding #Networking #LifeSciences Investor Mixer venue: THE ALAN BioCap venue: King's House Conference Centre
Bionow’s Post
More Relevant Posts
-
Chief Executive Officer (CEO) and Co-founder, Tinkeso Therapeutics (formerly ImmunoKite Therapeutics)
Join me at the BIO CEO & Investor Conference - one of the largest investor conferences in our industry where institutional investors, industry analysts, and senior executives are shaping the future investment landscape of biotechnology. #bioceo24
To view or add a comment, sign in
-
BioCentury's 2Q24 Public Markets Preview is now available: The market is finally on its way back, with palpable interest from investors, my BioCentury Inc. colleague Stephen Hansen finds. Unsurprisingly, he says, M&A has underpinned much of the recovery, with the takeouts a validation for both specialists and generalists that the biotech market is much healthier after the grueling bear market. PIPEs have once again been harbingers of biotech's recovery -- this time though Stephen says they are playing an outsized role in funding biotech's comeback. At nearly $8B, 1Q24's PIPEs represented the biggest single-quarter total for these offerings since we began tracking biotech financings 30 years ago.
PIPEs pave path to recovery
biocentury.com
To view or add a comment, sign in
-
A sobering assessment of London’s AIM market from my BioCentury Inc. colleague Stephen Hansen, following the recent de-listings of three U.K. biotechs. 💬 “Anybody who lists on AIM should not be surprised that there’s low liquidity and they can’t raise secondary financing.” - Tim Haines of Abingworth 💬 ✅ Full analysis: https://lnkd.in/d5VNEEKG #biotech #capitalmarkets
Delisting biotechs take AIM at U.K. exchange
biocentury.com
To view or add a comment, sign in
-
If you are attending the Biotechnology Innovation Organization's CEO & Investor Conference next month or will be around NYC during this time, feel free to reach out. Happy to chat with you and network if nothing else while I am in town. Join me at the BIO CEO & Investor Conference - one of the largest investor conferences in our industry where institutional investors, industry analysts, and senior executives are shaping the future investment landscape of biotechnology. #bioceo24
I've registered for BIO CEO & Investor Conference - join me.
invt.io
To view or add a comment, sign in
-
The biggest mistake Biotech founders and leaders make in fundraising? It's this.... This is something that's coming up on almost every episode of The Other Side of The Table, so if you're raising money right now or about to start, it's worth taking a moment to listen to what Lee Lindley of Mercia Ventures has to say on this. And to listen to the full episode, head over to https://lnkd.in/eyx2Csmq #biotech #techbio #healthtech #biotechnology #venturecapital #vcfunding #seedfunding #seriesa #seriesb #drugdiscovery #drugdevelopment
To view or add a comment, sign in
-
Macquarie Capital, the private equity arm of Macquarie Group, buys $32 million in BioCatch shares via secondary. This marks the third secondary transaction completed by BioCatch in the past year, with significant investments made by Sapphire Ventures and Permira Growth Opportunities in 2023. #Secondaries #Secondary #SecondaryMarket #AlternativeInvestments #PrivateMarkets #Venture #VentureCapital #VC #Deals https://lnkd.in/eZanTDC6
Macquarie Capital buys $32 million in BioCatch shares via secondary
secondarylink.com
To view or add a comment, sign in
-
There’s a new opportunity on the InvestaMatch horizon - Kimer Med, a NZ biotech company. Stay tuned. #investaMatch #NZInvestment #SmallBusinessInvestment #InvestInMyBusiness #StartupFunding #SeekingInvestors #FundMyBusiness
To view or add a comment, sign in
-
-
What is key for navigating the investment ecosystem? Here are a few tips: Leverage partnerships so you can focus only on a few things, don't use venture dollars for CAPEX, e.g. building out facilities, make sure to play devil's advocate when developing a realistic MVP. Very insightful! #venturecapital #investing #synbio #syntheticbiology #synbiobeta #synbiobeta2024
To view or add a comment, sign in
-
-
🧬Rob Moffat’s Top Biotech Picks🧬 Middlefield Portfolio Manager, Rob Moffat, CFA, recently joined BNN Bloomberg to share his top biotech stock picks going into the second half of 2024. #Biotech #Investing #Healthcare #InvestmentsThatWorkForYou
Rob Moffat's Top Biotech Picks - BNN Bloomberg's Hot Picks | Middlefield Group
middlefield.com
To view or add a comment, sign in
-
Here’s the Latest Announcements from Today! Check out the latest updates from companies on Liquidity. Follow your favourite companies and get ASX Announcement Highlights, tailored just for you, delivered direct to your inbox. Recharge Metals Limited | $REC Pointerra | $3DP Wide Open Agriculture | $WOA Structural Monitoring Systems Plc | $SMN Buxton Resources | $BUX Chariot Corporation Ltd | $CC9 Argenica Therapeutics | $AGN Strategic Elements Ltd | $SOR Parkd | $PKD 🔗 - https://lnkd.in/gMUKDxdF #Liquidity #ASX #Investing #Announcements #MarketUpdates #InvestmentNews
To view or add a comment, sign in